ACHV Biotech
ACHV had good earnings in mid-March and has been in an ascending triangle since that time.
The uptrend had a correction April 17th to 20th to which buyers responded with spiking
buying volume. Current volume is 3x relative to the usual and customary historical volume
averages.
I will take a long trade on this when price descends to the support trendline as notified by
an alert set on Tradingview. The target is the post covid highs of $ 17.00 . This is modest
compared with the average upside of the analysts of $ 22+ ( see the link below)
I will take out a sizeable stock position and also some insurance in the form of a long term
put option to manage the risk on the trade.
The uptrend had a correction April 17th to 20th to which buyers responded with spiking
buying volume. Current volume is 3x relative to the usual and customary historical volume
averages.
I will take a long trade on this when price descends to the support trendline as notified by
an alert set on Tradingview. The target is the post covid highs of $ 17.00 . This is modest
compared with the average upside of the analysts of $ 22+ ( see the link below)
I will take out a sizeable stock position and also some insurance in the form of a long term
put option to manage the risk on the trade.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.